
Bluestem Capital
Description
Bluestem Capital is a private equity firm headquartered in Sioux Falls, South Dakota, specializing in providing capital solutions to middle-market companies. The firm's core investment strategies include recapitalizations, management buyouts, and mezzanine financing. Unlike traditional venture capital firms that focus on early-stage startups, Bluestem Capital targets established businesses, aiming to support growth, facilitate ownership transitions, or optimize capital structures. Their regional focus primarily extends to companies located in the Midwest, leveraging their deep understanding of the local economic landscape.
The firm typically seeks to make equity investments ranging from $5 million to $25 million. This substantial check size indicates their commitment to providing meaningful capital infusions for their portfolio companies. Bluestem Capital is particularly interested in businesses with enterprise values generally falling between $20 million and $100 million, signifying their focus on mature, revenue-generating entities rather than nascent ventures. Their investment approach is characterized by a partnership model, working closely with management teams to drive operational improvements and strategic growth initiatives.
Bluestem Capital's portfolio spans a diverse range of industries, including manufacturing, business services, distribution, and consumer products. The firm emphasizes long-term value creation, often participating in situations where a company requires capital for expansion, acquisitions, or shareholder liquidity events. Their expertise in structuring complex financial transactions, combined with a hands-on approach, positions them as a strategic partner for companies navigating various stages of their corporate lifecycle.
Investor Profile
Bluestem Capital has backed more than 28 startups, with 1 new investments in the last 12 months alone. The firm has led 11 rounds, about 39% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Medical, Advanced Materials.
- Typical check size: $5M – $25M.
Stage Focus
- Series Unknown (32%)
- Series B (29%)
- Series A (21%)
- Series C (14%)
- Series D (4%)
Country Focus
- United States (96%)
- Israel (4%)
Industry Focus
- Health Care
- Medical
- Advanced Materials
- Developer Platform
- Robotics
- Pharmaceutical
- Medical Device
- Software
- Biotechnology
- Analytics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.